NasdaqGS:UTHRBiotechs
Is It Too Late To Consider United Therapeutics (UTHR) After A 106% One-Year Surge?
If you are wondering whether United Therapeutics at around US$574.77 is priced attractively or already reflects high expectations, you are in the right place.
The stock has posted returns of 1.8% over the past week, 7.3% over the last month, 15.7% year to date, and 106.1% over the past year, with 3 year and 5 year returns of 148.0% and 185.0% respectively.
Recent coverage has focused on United Therapeutics' position in the pharmaceuticals and biotech space and how market sentiment around the...